Chemotaxis of human osteoblasts. Effects of osteotropic growth factors.
Martin Lind(Aarhus University Hospital), Cody Bünger(Aarhus University Hospital), Kristian Thestrup‐Pedersen(Gentofte Hospital), Bent Deleuran(Aarhus University), Kjeld Søballé(Aarhus University Hospital), Erik Fink Eriksen(Osteoporosis Canada)
PubMed
February 1, 1995
Cited by 98
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
|PEDIATRICS|2009|409
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
|New England Journal of Medicine|2012|361
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women With Osteoporosis
|Obstetrical & Gynecological Survey|2001|307